HealthEquity Company Profile (NASDAQ:HQY)

About HealthEquity (NASDAQ:HQY)

HealthEquity logoHealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Its products and services include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements and healthcare incentives. Its ecosystem primarily consists of HSA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:HQY
  • CUSIP: N/A
  • Web:
  • Market Cap: $3.09 billion
  • Outstanding Shares: 60,488,000
Average Prices:
  • 50 Day Moving Avg: $48.37
  • 200 Day Moving Avg: $47.16
  • 52 Week Range: $30.34 - $54.95
  • Trailing P/E Ratio: 73.89
  • Foreward P/E Ratio: 70.96
  • P/E Growth: 2.16
Sales & Book Value:
  • Annual Revenue: $202.47 million
  • Price / Sales: 15.26
  • Book Value: $5.23 per share
  • Price / Book: 9.77
  • EBITDA: $61.84 million
  • Net Margins: 20.27%
  • Return on Equity: 13.93%
  • Return on Assets: 13.27%
  • Current Ratio: 18.52%
  • Quick Ratio: 18.49%
  • Average Volume: 525,565 shs.
  • Beta: 1.8
  • Short Ratio: 11.62

Frequently Asked Questions for HealthEquity (NASDAQ:HQY)

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings results on Tuesday, September, 5th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.13. The firm earned $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business's revenue was up 28.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.16 EPS. View HealthEquity's Earnings History.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY18 earnings guidance on Tuesday, September, 5th. The company provided earnings per share (EPS) guidance of $0.64-$0.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.66. The company issued revenue guidance of $223-$228 million, compared to the consensus revenue estimate of $224.83 million.

Where is HealthEquity's stock going? Where will HealthEquity's stock price be in 2017?

9 brokers have issued twelve-month target prices for HealthEquity's shares. Their predictions range from $51.00 to $61.00. On average, they expect HealthEquity's stock price to reach $57.00 in the next year. View Analyst Ratings for HealthEquity.

What are analysts saying about HealthEquity stock?

Here are some recent quotes from research analysts about HealthEquity stock:

  • 1. According to Zacks Investment Research, "HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. " (10/11/2017)
  • 2. Cantor Fitzgerald analysts commented, "Remains confident that HSA language will be included in subsequent legislative action, even if current ACA legislation fails to advance." (9/25/2017)
  • 3. Chardan Capital analysts commented, "Tuesday after market close HealthEquity released F4Q17 earnings with a 12% beat on adj. EBITDA driven by strong performance in their Custodial and Interchange lines of business. The company also guided to 79.5m in adj. EBITDA in F2018E, 1% above Street Consensus. We liked Management's commitment to strong financial performance and their confidence in the demand they see for HSAs in the market during their ongoing selling season. We raise our PT to $53 (from $50) based on the company's higher multiple and reiterate our Buy rating." (3/22/2017)
  • 4. FIX analysts commented, "HealthEquity, as a pure play provider of tax-advantaged health accounts and related services, is perfectly positioned to take advantage of favorable regulatory changes and the increasing shift of healthcare costs toward consumers. Among the various ACA repeal & replace proposals in DC, the one constant appears to be the push to provide ownership to consumers along with first-dollar responsibility through tax-advantaged accounts such as HSAs. A large number of employers have already embarked on this path, and the regulatory shift could significantly speed up this change and drive faster adoption. While HQY shares have moved up post-election in anticipation of favorable changes in consumer-directed health accounts, we believe there is still upside to growth and valuation. Initiate with Outperform, $58 target." (3/14/2017)

Who are some of HealthEquity's key competitors?

Who are HealthEquity's key executives?

HealthEquity's management team includes the folowing people:

  • Robert W. Selander, Independent Chairman of the Board
  • Jon Kessler, President, Chief Executive Officer, Director
  • Stephen D. Neeleman M.D., Vice Chairman of the Board, Founder
  • Darcy G. Mott, Chief Financial Officer, Executive Vice President
  • Ashley Dreier, Executive Vice President, Chief Technology Officer and Chief Information Officer
  • Gary Robinson, Executive Vice President, Chief Marketing Officer
  • Delano W. Ladd, Executive Vice President, General Counsel and Corporate Secretary
  • William Otten, Executive Vice President of Sales
  • Jonathan Soldan, Executive Vice President - Operations
  • Gayle Wellborn, Director

Who owns HealthEquity stock?

HealthEquity's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Sanders Morris Harris LLC (0.08%) and Strs Ohio (0.04%). Company insiders that own HealthEquity stock include Adrian T Dillon, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman. View Institutional Ownership Trends for HealthEquity.

Who sold HealthEquity stock? Who is selling HealthEquity stock?

HealthEquity's stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio. Company insiders that have sold HealthEquity stock in the last year include Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney and Stephen Neeleman. View Insider Buying and Selling for HealthEquity.

Who bought HealthEquity stock? Who is buying HealthEquity stock?

HealthEquity's stock was purchased by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC. View Insider Buying and Selling for HealthEquity.

How do I buy HealthEquity stock?

Shares of HealthEquity can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HealthEquity's stock price today?

One share of HealthEquity stock can currently be purchased for approximately $51.09.

MarketBeat Community Rating for HealthEquity (NASDAQ HQY)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  188 (Vote Outperform)
Underperform Votes:  123 (Vote Underperform)
Total Votes:  311
MarketBeat's community ratings are surveys of what our community members think about HealthEquity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for HealthEquity (NASDAQ:HQY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: $57.00 (11.57% upside)
Consensus Price Target History for HealthEquity (NASDAQ:HQY)
Price Target History for HealthEquity (NASDAQ:HQY)
Analysts' Ratings History for HealthEquity (NASDAQ:HQY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/25/2017Cantor FitzgeraldReiterated RatingBuy$56.00LowView Rating Details
9/21/2017Robert W. BairdReiterated RatingNeutral -> HoldMediumView Rating Details
9/6/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$61.00LowView Rating Details
6/7/2017Chardan CapitalBoost Price TargetBuy -> Buy$53.00 -> $57.00HighView Rating Details
3/22/2017J P Morgan Chase & CoBoost Price TargetOverweight$44.00 -> $51.00HighView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformMediumView Rating Details
3/14/2017FIXInitiated CoverageOutperformMediumView Rating Details
3/14/2017Wells Fargo & CompanyInitiated CoverageOutperformMediumView Rating Details
1/23/2017KeyCorpInitiated CoverageOverweight$60.00N/AView Rating Details
9/12/2016Raymond James Financial, Inc.Boost Price TargetOutperform$32.00 -> $40.00N/AView Rating Details
9/8/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
9/8/2016Barrington ResearchBoost Price TargetOutperform$34.00 -> $38.00N/AView Rating Details
6/8/2016Leerink SwannReiterated RatingOutperform$30.00 -> $33.00N/AView Rating Details
3/23/2016Avondale PartnersBoost Price TargetMarket Outperform$25.00 -> $27.00N/AView Rating Details
(Data available from 10/23/2015 forward)


Earnings History for HealthEquity (NASDAQ:HQY)
Earnings by Quarter for HealthEquity (NASDAQ:HQY)
Earnings History by Quarter for HealthEquity (NASDAQ HQY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/5/2017Q2 2018$0.14$0.27$55.66 million$56.90 millionViewListenView Earnings Details
6/6/2017Q1 2018$0.16$0.19$54.77 million$55.40 millionViewListenView Earnings Details
3/21/2017Q4 2017$0.05$0.07$45.55 million$46.83 millionViewN/AView Earnings Details
12/6/2016Q3 2017$0.09$0.10$43.29 million$43.36 millionViewN/AView Earnings Details
9/6/2016Q2$0.13$0.16$43.28 million$44.19 millionViewN/AView Earnings Details
6/7/2016Q1$0.13$0.15$42.06 million$44.01 millionViewN/AView Earnings Details
3/22/2016Q4$0.04$0.07$34.90 million$35.89 millionViewListenView Earnings Details
12/7/2015Q316$0.07$0.08$31.09 million$30.60 millionViewN/AView Earnings Details
9/8/2015Q216$0.08$0.08$29.81 million$30.50 millionViewN/AView Earnings Details
6/8/2015Q116$0.08$0.09$28.65 million$29.90 millionViewN/AView Earnings Details
3/24/2015Q415$0.02$0.04$23.50 million$24.90 millionViewN/AView Earnings Details
12/9/2014Q315$0.04$0.05$21.00 million$21.90 millionViewN/AView Earnings Details
9/9/2014Q2 15$0.05$0.07$20.32 million$20.89 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for HealthEquity (NASDAQ:HQY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for HealthEquity (NASDAQ:HQY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for HealthEquity (NASDAQ:HQY)
Insider Ownership Percentage: 29.00%
Institutional Ownership Percentage: 90.97%
Insider Trades by Quarter for HealthEquity (NASDAQ:HQY)
Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)
Insider Trades by Quarter for HealthEquity (NASDAQ:HQY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/12/2017Berkley Capital, LlcMajor ShareholderSell11,395$51.91$591,514.45View SEC Filing  
10/9/2017Berkley Capital, LlcMajor ShareholderSell1,100$51.95$57,145.00View SEC Filing  
10/9/2017Frank MediciDirectorSell316,644$51.96$16,452,822.24View SEC Filing  
10/6/2017Berkley Capital, LlcMajor ShareholderSell29,032$51.97$1,508,793.04View SEC Filing  
10/5/2017Berkley Capital, LlcMajor ShareholderSell286,512$51.96$14,887,163.52View SEC Filing  
9/20/2017Darcy G MottVPSell9,500$46.79$444,505.00View SEC Filing  
9/15/2017Stephen NeelemanInsiderSell8,500$45.24$384,540.00View SEC Filing  
9/6/2017Ashley DreierVPSell10,000$45.50$455,000.00View SEC Filing  
8/28/2017Jon SoldanVPSell25,000$40.68$1,017,000.00View SEC Filing  
8/21/2017Darcy G MottVPSell9,500$42.00$399,000.00View SEC Filing  
8/15/2017Stephen NeelemanInsiderSell8,500$46.65$396,525.00View SEC Filing  
7/17/2017Stephen NeelemanInsiderSell8,500$50.83$432,055.00View SEC Filing  
7/14/2017Berkley Capital, LlcMajor ShareholderSell72,791$51.41$3,742,185.31View SEC Filing  
7/14/2017Frank MediciDirectorSell537,102$51.24$27,521,106.48View SEC Filing  
7/13/2017Frank MediciDirectorSell131,800$51.42$6,777,156.00View SEC Filing  
7/12/2017Frank MediciDirectorSell332,511$51.13$17,001,287.43View SEC Filing  
7/7/2017Berkley Capital, LlcMajor ShareholderSell210,398$50.26$10,574,603.48View SEC Filing  
7/7/2017Frank MediciDirectorSell186,749$50.26$9,386,004.74View SEC Filing  
7/5/2017Frank MediciDirectorSell23,649$50.27$1,188,835.23View SEC Filing  
6/26/2017Berkley Capital, LlcMajor ShareholderSell56,067$51.79$2,903,709.93View SEC Filing  
6/23/2017Berkley Capital, LlcMajor ShareholderSell54,967$51.78$2,846,191.26View SEC Filing  
6/21/2017Berkley Capital, LlcMajor ShareholderSell129,263$51.95$6,715,212.85View SEC Filing  
6/21/2017Frank MediciDirectorSell154,265$51.94$8,012,524.10View SEC Filing  
6/20/2017Berkley Capital, LlcMajor ShareholderSell21,000$51.86$1,089,060.00View SEC Filing  
6/19/2017Berkley Capital, LlcMajor ShareholderSell4,002$51.99$208,063.98View SEC Filing  
6/15/2017Stephen NeelemanInsiderSell8,500$50.40$428,400.00View SEC Filing  
6/14/2017Frank MediciDirectorSell210,906$52.03$10,973,439.18View SEC Filing  
6/13/2017Berkley Capital, LlcMajor ShareholderSell248,351$52.80$13,112,932.80View SEC Filing  
6/5/2017Ashley DreierVPSell10,000$47.81$478,100.00View SEC Filing  
6/2/2017Stephen NeelemanInsiderSell40,000$48.36$1,934,400.00View SEC Filing  
5/1/2017Jon KesslerInsiderSell30,000$45.43$1,362,900.00View SEC Filing  
4/20/2017Darcy G MottVPSell10,000$43.44$434,400.00View SEC Filing  
4/17/2017Stephen NeelemanInsiderSell8,500$43.45$369,325.00View SEC Filing  
4/13/2017Delano LaddEVPSell1,095$43.60$47,742.00View SEC Filing  
4/4/2017Jon KesslerInsiderSell30,000$42.24$1,267,200.00View SEC Filing  
4/3/2017Jon KesslerCEOSell20,000$41.85$837,000.00View SEC Filing  
3/30/2017Adrian T. DillonDirectorBuy5,000$40.53$202,650.00View SEC Filing  
3/24/2017Jon SoldanVPSell6,250$41.95$262,187.50View SEC Filing  
3/22/2017Stephen NeelemanInsiderSell1,200$46.18$55,416.00View SEC Filing  
3/20/2017Ashley DreierVPSell5,000$45.80$229,000.00View SEC Filing  
3/20/2017Darcy G MottCFOSell10,000$45.92$459,200.00View SEC Filing  
3/20/2017Stephen NeelemanInsiderSell55,518$46.19$2,564,376.42View SEC Filing  
3/17/2017Stephen NeelemanVice ChairmanSell53,218$46.20$2,458,671.60View SEC Filing  
3/16/2017Stephen NeelemanInsiderSell40,169$45.96$1,846,167.24View SEC Filing  
2/28/2017Stephen NeelemanVice ChairmanSell1,600$44.02$70,432.00View SEC Filing  
2/27/2017Stephen NeelemanVice ChairmanSell215$44.00$9,460.00View SEC Filing  
2/21/2017Darcy G MottCFOSell10,000$42.60$426,000.00View SEC Filing  
1/20/2017Darcy G MottVPSell10,000$47.73$477,300.00View SEC Filing  
1/19/2017Frank MediciDirectorSell1,000,000$46.45$46,450,000.00View SEC Filing  
1/3/2017Frank CorvinoDirectorSell35,000$40.33$1,411,550.00View SEC Filing  
12/20/2016Darcy G MottVPSell10,000$40.12$401,200.00View SEC Filing  
12/20/2016Manu S RanaDirectorSell382,352$40.72$15,569,373.44View SEC Filing  
12/9/2016Darcy G MottVPSell30,000$40.88$1,226,400.00View SEC Filing  
11/28/2016Ashley DreierVPSell5,000$43.38$216,900.00View SEC Filing  
11/1/2016Matthew SydneyVPSell25,000$32.52$813,000.00View SEC Filing  
10/25/2016Frank MediciDirectorSell2,205,884$35.85$79,080,941.40View SEC Filing  
10/20/2016Darcy G MottVPSell10,000$35.37$353,700.00View SEC Filing  
10/13/2016Stephen NeelemanInsiderSell30,000$36.19$1,085,700.00View SEC Filing  
9/20/2016Darcy G MottCFOSell10,000$35.03$350,300.00View SEC Filing  
9/20/2016Jon KesslerCEOSell54,712$35.07$1,918,749.84View SEC Filing  
9/19/2016Jon KesslerCEOSell65,288$35.02$2,286,385.76View SEC Filing  
9/15/2016Jon KesslerInsiderSell20,000$33.46$669,200.00View SEC Filing  
9/13/2016Stephen NeelemanInsiderSell30,000$33.22$996,600.00View SEC Filing  
9/12/2016Jon KesslerInsiderSell120,117$33.10$3,975,872.70View SEC Filing  
9/12/2016Jon SoldanVPSell25,000$33.55$838,750.00View SEC Filing  
9/1/2016Ashley DreierVPSell10,000$32.28$322,800.00View SEC Filing  
8/31/2016Jon KesslerInsiderSell34,883$33.00$1,151,139.00View SEC Filing  
8/23/2016Stephen NeelemanInsiderSell9,898$30.28$299,711.44View SEC Filing  
8/22/2016Darcy G MottCFOSell10,000$29.13$291,300.00View SEC Filing  
8/18/2016Stephen NeelemanInsiderSell102$30.00$3,060.00View SEC Filing  
7/25/2016Jon KesslerInsiderSell10,000$29.62$296,200.00View SEC Filing  
7/20/2016Darcy G MottVPSell10,000$30.23$302,300.00View SEC Filing  
7/15/2016Ian SacksDirectorSell100,000$30.27$3,027,000.00View SEC Filing  
7/15/2016Jon KesslerCEOSell10,000$30.05$300,500.00View SEC Filing  
7/13/2016Stephen NeelemanVice ChairmanSell30,000$30.52$915,600.00View SEC Filing  
6/30/2016Stephen NeelemanVice ChairmanSell17,967$30.20$542,603.40View SEC Filing  
6/23/2016Jon KesslerCEOSell10,000$29.00$290,000.00View SEC Filing  
6/23/2016Michael O LeavittDirectorSell6,250$29.17$182,312.50View SEC Filing  
6/22/2016Michael O LeavittDirectorSell28,083$29.16$818,900.28View SEC Filing  
6/20/2016Darcy G MottCFOSell10,000$29.30$293,000.00View SEC Filing  
6/15/2016Jon KesslerCEOSell110,000$29.17$3,208,700.00View SEC Filing  
6/14/2016Jon KesslerCEOSell38,119$29.09$1,108,881.71View SEC Filing  
6/13/2016Jon KesslerCEOSell6,288$29.02$182,477.76View SEC Filing  
6/13/2016Stephen NeelemanVice ChairmanSell20,000$28.87$577,400.00View SEC Filing  
6/9/2016Manu S RanaDirectorSell500,000$28.30$14,150,000.00View SEC Filing  
6/8/2016Stephen NeelemanVice ChairmanSell2,033$30.12$61,233.96View SEC Filing  
5/26/2016Stephen NeelemanVice ChairmanSell19,900$25.03$498,097.00View SEC Filing  
5/25/2016Darcy G MottCFOSell10,000$25.00$250,000.00View SEC Filing  
5/13/2016Stephen NeelemanVice ChairmanSell100$25.00$2,500.00View SEC Filing  
5/11/2016Jon KesslerCEOSell52,000$25.21$1,310,920.00View SEC Filing  
4/20/2016Darcy G MottCFOSell10,000$25.52$255,200.00View SEC Filing  
4/11/2016Manu S RanaDirectorSell500,000$23.48$11,740,000.00View SEC Filing  
4/4/2016Jon KesslerCEOSell93,000$25.06$2,330,580.00View SEC Filing  
4/1/2016Darcy G MottCFOSell30,000$25.00$750,000.00View SEC Filing  
1/4/2016Stephen NeelemanVice ChairmanSell11,346$25.03$283,990.38View SEC Filing  
12/21/2015Darcy G. MottCFOSell10,000$25.70$257,000.00View SEC Filing  
12/2/2015Stephen NeelemanVice ChairmanSell37,500$32.75$1,228,125.00View SEC Filing  
12/1/2015Ashley DreierVPSell3,125$32.32$101,000.00View SEC Filing  
11/20/2015Darcy G. MottCFOSell10,000$33.64$336,400.00View SEC Filing  
11/11/2015Matthew SydneyVPSell35,000$35.00$1,225,000.00View SEC Filing  
10/28/2015Jon KesslerCEOSell20,000$32.00$640,000.00View SEC Filing  
10/20/2015Darcy G. MottCFOSell10,000$30.28$302,800.00View SEC Filing  
10/1/2015Jon KesslerCEOSell35,000$28.92$1,012,200.00View SEC Filing  
9/25/2015Frank MediciDirectorSell2,300,000$29.50$67,850,000.00View SEC Filing  
9/22/2015Frank MediciDirectorSell12,500$29.56$369,500.00View SEC Filing  
9/21/2015Darcy G. MottCFOSell10,000$30.50$305,000.00View SEC Filing  
9/17/2015Michael O LeavittDirectorSell93,703$29.82$2,794,223.46View SEC Filing  
9/16/2015Ian SacksDirectorSell50,000$29.74$1,487,000.00View SEC Filing  
9/15/2015Ian SacksDirectorSell50,000$29.99$1,499,500.00View SEC Filing  
9/14/2015Michael O LeavittDirectorSell41,297$30.57$1,262,449.29View SEC Filing  
9/11/2015Stephen NeelemanVice ChairmanSell50,000$30.06$1,503,000.00View SEC Filing  
9/3/2015Ashley DreierVPSell3,125$30.00$93,750.00View SEC Filing  
9/1/2015Jon KesslerCEOSell35,000$28.97$1,013,950.00View SEC Filing  
6/15/2015Ashley DreierVPSell3,125$28.50$89,062.50View SEC Filing  
5/11/2015Berkley Capital Investors, L.PMajor ShareholderSell2,250,000$24.86$55,935,000.00View SEC Filing  
5/11/2015Darcy G MottCFOSell120,000$24.86$2,983,200.00View SEC Filing  
5/11/2015Frank MediciDirectorSell1,125,000$24.86$27,967,500.00View SEC Filing  
5/11/2015Jon KesslerCEOSell100,000$24.86$2,486,000.00View SEC Filing  
4/28/2015Ashley DreierVPSell3,125$27.00$84,375.00View SEC Filing  
8/5/2014Darcy G MottCFOBuy2,000$14.00$28,000.00View SEC Filing  
8/5/2014Frank MediciDirectorBuy12,500$14.00$175,000.00View SEC Filing  
8/5/2014Frode JensenVPBuy3,000$14.00$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for HealthEquity (NASDAQ:HQY)
Latest Headlines for HealthEquity (NASDAQ:HQY)
Loading headlines, please wait.



HealthEquity (HQY) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.